1-6 of 6
Gregory L. Price, MPH
Close
Sort by
Journal Articles

Phase I Study Of LY2784544, a JAK2 Selective Inhibitor, In Patients With Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srdan Verstovsek, MD, PhD, Ruben A Mesa, MD, Mohamed E Salama, MD, Jennifer L K Giles, BSc, Celine Pitou, PharmD, Annamaria Hayden Zimmermann, MS, Gregory L Price, MPH, Richard A Walgreen, MD, Josef Prchal, MD
Journal: Blood
Blood (2013) 122 (21): 665.
https://doi.org/10.1182/blood.V122.21.665.665
Published: 2013
Journal Articles

Comorbidity Burden in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Keith L Davis, MA, Gregory L Price, MPH, Sudeep Karve, PhD, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1734.
https://doi.org/10.1182/blood.V120.21.1734.1734
Published: 2012
Journal Articles

Health Care Utilization and Associated Costs in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Sudeep Karve, PhD, Gregory L Price, MPH, Keith L Davis, MA, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4273.
https://doi.org/10.1182/blood.V120.21.4273.4273
Published: 2012
Journal Articles

Survival Patterns in Patients with Non-CML Myeloproliferative Neoplasms: Evidence From a United States SEER/Medicare Population

Gregory L. Price, MPH, Keith L Davis, MA, Sudeep Karve, PhD, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 428.
https://doi.org/10.1182/blood.V120.21.428.428
Published: 2012
Journal Articles

A Retrospective Observational Study of Annual Healthcare Costs for Patients with Forms of Myeloproliferative Neoplasms (MPN)

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2060.
https://doi.org/10.1182/blood.V118.21.2060.2060
Published: 2011
Journal Articles

A Retrospective Observational Comparison of Comorbidities Between Myeloproliferative Neoplasm (MPN) Patients and Matched Controls in a Commercially Insured US Population

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3140.
https://doi.org/10.1182/blood.V118.21.3140.3140
Published: 2011